QualityStocksNewsBreaks – Singular Research Initiates Coverage on EVIO, Inc. (EVIO)
Singular Research, a supplier of independent, single-source research on smallcap and microcap companies, recently initiated coverage with a ‘BUY’ rating and a price target of $2.00 on shares of EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry. Among other highlights, the report notes EVIO’s future growth prospects that are driven by investment capital, the rollout of new laboratories nationwide and the addition of new executive management members. To view the full report, visit http://ibn.fm/Sqdcz To view the full press release, visit http://ibn.fm/foCUN About EVIO, Inc. EVIO, Inc. is a life…